Pharmacologic Boosting of Atazanavir in Maintenance HIV-1 Therapy: The COREYA Propensity-Score Adjusted Study

BACKGROUND: Among HIV-1 infected patients who achieved virologic suppression, the use of atazanavir without pharmacologic boosting is debated. We evaluated the efficacy and tolerance of maintenance therapy with unboosted atazanavir in clinical practice. METHODS AND RESULTS: This multicenter retrospe...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Hocqueloux, Laurent, Choisy, Philippe, Le Moal, Gwenaël, Borsa-Lebas, Françoise, Plainchamp, David, Legac, Eric, Prazuck, Thierry, de la Tribonnière, Xavier, Yazdanpanah, Yazdan, Parienti, Jean-Jacques
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2012
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3494679/
https://ncbi.nlm.nih.gov/pubmed/23152890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0049289
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki